Parallax Volatility Advisers, L.P. Halozyme Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $327,343 - $432,440	-8,428 Reduced 99.22%	66 $3,000
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $130,314 - $182,420	-9,776 Reduced 53.51%	8,494 $124,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $306,022 - $380,016	18,270	18,270 $370,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.